Dublin, March 23, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/w8233k/global_3d) has announced the addition of the "Global 3D Bioprinting Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global 3D Bioprinting Market is poised to grow at a CAGR of around 16.7% over the next decade to reach approximately $8.9 billion by 2025.
This industry report analyzes the global markets for 3D Bioprinting across all the given segments on global as well as regional levels presented in the research scope. It presents historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report provides comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.
The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Tissue Engineering and Dental Implants Set to Boost 3D Bioprinting
3.1.2 Recent Techlological Developments of 3D bioprinting
3.1.3 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
4 3D bioprinting Market, By Technology
4.1 Laser assisted
4.2 Syringe Based
4.3 Magnetic Levitation
4.4 Valve-based
4.5 Inkjet Based
5 3D bioprinting Market, By Application
5.1 Consumer/personal product testing
5.2 Food And Animal Product
5.3 Biosensors
5.4 Dental
5.5 Bioinks
5.6 Medical
6 3D bioprinting Market, By Geography
7 Leading Companies
- 3D Biotek
- 3D Systems
- Advanced Biomatrix
- Autodesk
- Avita Medical
- BD Biosciences
- Bespoke Innovations
- Bio3D Technologies
- CMC Microsystems
- Cyfuse Biomedical
- DTM
- Digilab
- EnvisionTEC
- TeVido BioDevices
- United Therapeutics
For more information visit http://www.researchandmarkets.com/research/w8233k/global_3d
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: 3D Printing


Want to cut your energy bills? Here’s how five experts are doing it
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 



